Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -1.12% | -5.88% | -88.04% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 167K | Capitalization | 121M |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | -84M | EV / Sales 2024 * | 0.68 x |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | 168M | EV / Sales 2025 * | -284 x |
P/E ratio 2024 * |
-1.16
x | P/E ratio 2025 * |
-1.5
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.07% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | -1.12% | ||
1 week | -11.11% | ||
Current month | -38.03% | ||
1 month | -38.89% | ||
3 months | -88.85% | ||
6 months | -88.82% | ||
Current year | -88.04% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 237 M€ | +2.89% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.76 | -1.12% | 5,217,740 |
24-04-25 | 1.78 | -5.32% | 2,479,181 |
24-04-24 | 1.88 | -3.59% | 1,741,628 |
24-04-23 | 1.95 | -1.52% | 1,471,449 |
24-04-22 | 1.98 | +5.88% | 1,555,644 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.04% | 121M | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- AMLX Stock